NOV 07, 2018 8:15 AM PST

Modifying Antibiotics For Drug Resistant Infections

WRITTEN BY: Nouran Amin

Credit: CancerCenter.com

In a study published in Nature Chemistry, researches at MIT were able to create a new chemical reaction that has the ability to modify antibiotics to make them more effective against drug-resistant infections.

One example demonstrated is the antibiotic vancomycin which was chemically linked to an antimicrobial peptide and was able to dramatically enhance the antibiotic’s effectiveness against two strains of drug-resistant bacteria.

"Typically, a lot of steps would be needed to get vancomycin in a form that would allow you to attach it to something else, but we don't have to do anything to the drug," says an MIT associate professor of chemistry and senior of the study--Brad Pentelute. "We just mix them together and we get a conjugation reaction."

The novel reaction could be used to alter other types of drugs, particularly onco-drugs.

The researchers found that in linking up these peptides with vancomycin, the chemical bonds were consistent in occurring at the same location resulting in molecules that were identical. Existing tools for linking complex molecules make it difficult to produce a pure product. However, the attachment of drugs to an antibody or another targeting protein will make it easier for these drugs to reach their target.

“By chemically linking the antibiotic vancomycin to two different antimicrobial peptides, MIT researchers were able to dramatically enhance the drug’s effectiveness against two strains of drug-resistant bacteria: A. baumannii and E. faecalis.” –ScienceDaily

 Credit: Image: U.S. Centers for Disease Control and Prevention

"That's the beauty of this method," says MIT postdoc Chi Zhang. "These complex molecules intrinsically possess regions that can be harnessed to conjugate to our protein, if the protein possesses the selenocysteine handle that we developed. It can greatly simplify the process."

Additionally, the researchers hope that through the modifications of antibiotics—it can be used for the development of cancer drugs. Their study can be use to create effective cancer drugs that will reach their targeted destination without cause debilitating effects to healthy tissue.

Source: Massachusetts Institute of Technology

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 13, 2020
Cardiology
APR 13, 2020
Computer Model Predicts How Drugs Affect Heart Rhythm
Cardiotoxicity, heart electrophysiology dysfunction or muscle damage,  is one of the most common reasons why drugs ...
APR 25, 2020
Cannabis Sciences
APR 25, 2020
Researchers Trial Cannabis to Treat COVID-19
Researchers in Israel are investigating the potential for cannabis-derived products to treat patients with COVID-19. So ...
APR 24, 2020
Drug Discovery & Development
APR 24, 2020
Combination Immunotherapy Allows Immune Cells To Target Tumors
A drug combination of immunotherapeutic agents encourages immune cells to devour cancer cells according to findings publ ...
MAY 04, 2020
Cancer
MAY 04, 2020
A Retroactive Study Finds an Immunotherapy Effective as a Third-Line Therapy
Cancer is a particularly persistent disease. Many therapies are composed of one or more different treatments. These trea ...
MAY 03, 2020
Drug Discovery & Development
MAY 03, 2020
Hydroxychloroquine: The Controversial Use
COVID-19 was declared a public health threat on January 30th and since then it took the world by a storm with more than ...
MAY 26, 2020
Drug Discovery & Development
MAY 26, 2020
Everyone Can Produce Antibodies Against COVID-19
Researchers at Rockefeller University in New York have found that most people exposed to COVID-19, and who experience sy ...
Loading Comments...